AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.

Beckman Coulter Life Sciences, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research.

BrightSpec, is launching its BrightSpec-MRR product suite at PittCon 2025. The instruments are designed to revolutionize the way analytical chemists identify and quantify complex molecular structures.

Ultima Genomics, Inc., announced expanded global access to high-quality, low-cost DNA sequencing with the addition of multiple new partnerships with leading genomic services providers.

Sphere Fluidics announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development.

Seer, Inc. (Nasdaq: SEER), announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025.